"I'm feeling great," said 19-year-old Caden Major.

Caden Major was born with sickle cell disease – an inherited blood disorder affecting red blood cells. Now at 19 years old, ...

Less than a third of ED visits for acute sickle cell disease pain were guideline-adherent for the timely administration of ...

Roseland Community Hospital on Monday celebrated the opening of a new sickle cell treatment clinic.

Guideline adherence for opioid pain medications was found to be suboptimal among patients with sickle cell disease pain in the ED.

Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an ...

Most people with sickle cell disease who undergo allogeneic hematopoietic cell transplantation achieve favorable long-term ...

Motixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) ...

At ASH 2025, Fulcrum presented promising data on a sickle cell pill and Incyte is pioneering a new way to treat myelofibrosis ...

Experts call for consistent, specialist care throughout life to prevent complications and improve outcomes for people with ...

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced the presentation of new preclinical data on ...

Patients who underwent hematopoietic cell transplantation for sickle cell disease saw high rates of survival without disease ...